Assessment of public interest and current trends in testosterone replacement therapy

Int J Impot Res. 2022 Dec;34(8):753-756. doi: 10.1038/s41443-021-00445-4. Epub 2021 May 18.

Authors

Wade Muncey^{1

2}, Danly Omil-Lima^{3

4}, Erin Jesse^{3

4}, Karishma Gupta^{3

4}, Ahmed ElShafei^{3

4}, Chad Heflick⁵, Aram Loeb^{3

4}, Nannan Thirumavalavan^{3

4}

Affiliations

¹ Case Western Reserve University School of Medicine, Cleveland, OH, USA. Wade.Muncey@UHhospitals.org.
² University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Wade.Muncey@UHhospitals.org.
³ Case Western Reserve University School of Medicine, Cleveland, OH, USA.
⁴ University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
⁵ Elson S. Floyd College of Medicine, Spokane, WA, USA.

PMID: 34007065
DOI: 10.1038/s41443-021-00445-4

No abstract available

MeSH terms

Hormone Replacement Therapy*
Humans
Hypogonadism* / drug therapy
Testosterone / therapeutic use

Substances

Testosterone